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Objectives: The aim of this study was to assess the relationship between the pericardial fat volume (PFV)
and the characteristics of coronary plaques in patients with ischemic heart disease (IHD).
Background: It has been suggested that pericardial adipose tissue promotes plaque development in
coronary artery disease (CAD).
Methods: We analyzed the cardiac computed tomography scans in consecutive patients suspected of
CAD. PFV was quantiﬁed using validated software and indexed to body surface area, and the severity of
coronary stenosis was evaluated in the patients who underwent coronary angiography. A total of 105
subjects (mean age, 68  10 years) with IHDwere categorized into tertiles of body surface area-indexed PFV
values (PFVi, cm3/m2): low-tertile, PFVi < 81.2 cm3/m2; mid-tertile, 81.2 cm3/m2  PFVi  114 cm3/m2;
high-tertile, PFVi > 114 cm3/m2. Their body mass index (BMI), waist circumference, Gensini score (GS), and
coronary plaque component were evaluated.
Results: The GS was signiﬁcantly different between the high-tertile and the low-tertile groups,
indicating a stepwise decrease in GS from high-tertile to mid-tertile and to low-tertile. PFVi had a
signiﬁcant positive correlation with BMI (p = 0.0001) and GS (p < 0.0001). However, no signiﬁcant
association was found between GS and BMI. On the multivariate analysis, high PFVi remained an
independent predictor for the coronary artery disease severity (p < 0.001), while BMI and waist
circumference were not independent predictors.
Conclusions: Obese patients were found to have more PFVi, and the characteristics of their coronary
lesions were more severe. Pericardial adipose tissue as unique ectopic fat might be more highly
associated with IHD progression.
 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.Introduction
Pericardial fat is a type of visceral adipose tissue (VAT) that is
deﬁnedas theadipose tissuebetweenthesurfaceof themyocardium
and the epicardium. Similar to other VAT, pericardial fat serves an
important endocrine and inﬂammatory function, given its direct
apposition to the myocardium and coronary arteries [1,2].
Pericardial fat may play a central role in the pathogenesis of
cardiovascular disease,mediated by its inﬂammatoryproperties [3].DOI of commentary article: http://dx.doi.org/10.1016/j.jjcc.2014.07.004.
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http://dx.doi.org/10.1016/j.jjcc.2014.03.015
0914-5087/ 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rightsKaya et al. [4] reported that an echocardiographic epicardial fat
thickness is independently associatedwith the presence of coronary
artery disease (CAD), and Dagvasumberel et al. [5] reported
epicardial adipose tissue/body surface area was the single predictor
for >50% coronary luminal narrowing in men. Recent studies
demonstrated that 64-multi detector computed tomography
(MDCT) is suitable for volumetric quantization. However, there
have been no reports on the association between the pericardial fat
volume (PFV) and the severity of coronary lesions. We, therefore,
hypothesized that the pericardial fat increased steeply in patients
with signiﬁcant CAD. In this study, body surface area-indexed PFV
(PFVi, cm3/m2) was measured by MDCT, and the relationship
between the PFVi and the severity of CADwas evaluated in patients
referred for coronary angiography.reserved.
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Study population
A total of 105 consecutive ischemic heart disease (IHD) patients
who underwent MDCT angiograms and coronary angiography
between May 2012 and September 2013 were evaluated. Patients
with a history of previous cardiac surgery, percutaneous coronary
intervention, symptomatic heart failure, acute coronary syndrome,
cardiomyopathy, and severe renal failure were excluded from the
study. Written, informed consent was obtained from all patients.
Cardiac computed tomography scan protocol
Cardiac CT scans were performed with MDCT scanner (Aquilion
64, Toshiba Medical Systems, Tokyo, Japan) used with parameters
as previously reported [6]. Reconstruction sets at 75% of the cardiac
cycle or at a particular optimal phase were prepared from the raw
data ﬁles. The contrast material (Omnipaque-300; Daiichi-Sankyo
Pharmaceutical, Tokyo, Japan) was administered using a mechani-
cal power injector through a 20-gauge cannula inserted into the
antecubital vein. To minimize differences in the arterial enhance-
ment across the patients, a body weight-tailored contrast material
dose (0.7 mL/kg) and ﬁxed injection duration (9 s) were used [7].
An oral b-blocker (metoprolol, 20 mg) was administered immedi-
ately prior to CT imaging to maintain heart rates at <65 bpm and
thus improve image resolution. The reconstructed CT image data
were transferred to a workstation for post-processing (ZIO M900,
Admin/ZIO, Tokyo, Japan).
Quantiﬁcation of epicardial fat volume with CT
PFV was measured three-dimensionally in all patients using
contrast-enhanced images, as reported previously [7–9]. Segmen-
tation of the overall volume was automatically interpolated using
manually deﬁned tracings. Next, PFV was quantiﬁed by calculating
the total volume of the tissue whose CT density ranged from 190
to 30 Hounsﬁeld units within the pericardial cavity using the
workstation (Fig. 1). We trimmed along the pericardial sac using
axial, coronal, and sagittal slices, volume-rendered images. PFV
was deﬁned as any adipose tissue located within the pericardial
sac. A slice 1 cm above the most cranial slice including the left
anterior descending coronary artery (LAD) was deﬁned to be the
superior border of the pericardial fat. Patients were categorized
according to tertiles of PFVi: low-tertile (PFVi < 81.2 cm3/m2,
n = 35); mid-tertile (81.2 cm3/m2  PFVi  114 cm3/m2, n = 35),
and high-tertile (PFVi > 114 cm3/m2, n = 35).
[(Fig._1)TD$FIG]
Fig. 1. Representative case with high pericardial fat volume of a 49-year-old male wi
angiography shows a signiﬁcant stenosis at the middle segment of the left anterior desc
tomography shows a large amount of pericardial fat (B). The parietal pericardium (open a
are visible. Solid arrows (B), fatty deposits within the atrial septum. And pericardial adipo
ventricle.Coronary angiography and analysis
Based on the modiﬁed AHA classiﬁcation, the coronary arteries
were divided into 17 segments, and the segments with a diameter
>2.0 mm were analyzed.
CAD was deﬁned as 75% stenosis (according to the American
Heart Association classiﬁcation) on conventional coronary angi-
ography. Conventional coronary angiograms were recorded in
multiple projections for the left and the right coronary arteries and
reviewed for signiﬁcant coronary artery obstructions by cardiol-
ogists unaware of the amounts of pericardial fat.
The Gensini score (GS), an index of the severity of coronary
lesions, was calculated as the sum of all segment scores [10].
Severity scores assigned to the speciﬁc percentage luminal
diameter reduction of the coronary artery segment were 32 for
100%, 16 for 99%, 8 for 75%, 2 for 50%, and 1 for 25%. Each principal
vascular segment was assigned amultiplier in accordance with the
functional signiﬁcance of the myocardial area supplied by that
segment: the left main coronary artery 5; the proximal segment
of the LAD 2.5; the proximal segment of the circumﬂex artery
2.5, and the mid-segment of the LAD 1.5.
Assessment of risk factors and covariates
Blood was drawn after an overnight fast. Hypertension was
deﬁned as a systolic blood pressure 130 mmHg, a diastolic blood
pressure 85 mmHg, or the use of an antihypertensive treatment.
A fasting triglyceride level  150 mg/dL and a high-density
lipoprotein (HDL) cholesterol level < 40 mg/dL were considered
abnormal. Diabetes mellitus was diagnosed based on the criteria
set by the World Health Organization or by the use of hypoglyce-
mic agents or insulin. Abdominal obesity was deﬁned as a waist
circumference 85 cm for Japanese males and 90 cm for
Japanese females [11]. Metabolic syndrome (MetS) was diagnosed
according to the modiﬁed Adult Treatment Panel III criteria, which
include thewaist circumferencewith the presence of three ormore
metabolic abnormalities [9].Statistical analysis
Categorical variables are reported as numbers (%), and
continuous variables are reported as mean  SD. The chi-square
test was used for comparing categorical variables, and the unpaired t-
test was used for continuous variables. A p-value < 0.05 was
considered signiﬁcant, and all tests were two-tailed. All analyses
were performed using SPSS 17.0 (SPSS Inc., Chicago, IL, USA).th metabolic syndrome with a waist circumference of 106 cm. Invasive coronary
ending coronary artery (A, arrow). Angiography with 64-multi detector computed
rrow), paracardial fat (P), epicardial fat (E), coronary sinus (CS), and esophagus (Eso)
se tissue has been reconstructed three-dimensionally (C). RV, right ventricle; LV, left
Table 1
Baseline characteristics of the study patients by tertiles of indexed pericardial fat
volume.
Parameters Indexed pericardial fat volume (cm3/m2)
Low-tertile Mid-tertile High-tertile
Number 35 35 35
Age 6510 708 6811
Male/female 27/8 23/12 26/9
Body mass index (kg/m2) 23.02.6 24.22.5 25.92.6*
Waist circumferences (cm) 859 878 938*
Hypertension (%) 22 (64) 25 (72) 26 (75)
Dyslipidemia (%) 28 (82) 23 (66) 26 (75)
LDL-cholesterol (mg/dL) 11325 11126 10631
HDL-cholesterol (mg/dL) 5412 4814 4512*
Triglycerides (mg/dL) 14488 13867 14761
Diabetes mellitus (%) 14 (39) 10 (28) 13 (38)
Fasting plasma glucose (mg/dL) 11927 11219 11325
Hemoglobin A1c (%) 6.51.2 6.2 0.8 6.41.2
Metabolic syndrome
(Adult Treatment Panel III) (%)
14 (39) 13 (38) 15 (44)
Current smoker (%) 19 (57) 20 (58) 18 (52)
Medications
Statins (%) 26 (75) 18 (52) 26 (75)
ACE inhibitors or ARBs (%) 19 (54) 20 (58) 22 (65)
Ejection fraction
on echocardiography, %
6411 667 6410
Data are presented as means SD, number of patients (%). LDL, low-density
lipoprotein; HDL, high-density lipoprotein; ACE, angiotensin-converting enzyme;
ARB, angiotensin II receptor blocker.
* p<0.05 compared to the low-tertile group.
Table 2
Comparison of MDCT and coronary angiography results for patients by tertiles of
indexed pericardial fat volume.
Parameters PFVi (cm3/m2)
Low-tertile Mid-tertile High-tertile
PFV (cm3) 11416 15922 24347*
PFVi (cm3/m2) 689 978 14426*
Coronary stenosis (375% diameter reduction)
1-Vessel disease, n (%) 20 (57) 23 (68) 14 (41)
2-Vessel disease, n (%) 9 (25) 6 (17) 10 (28)
3-Vessel disease, n (%) 6 (17) 5 (14) 11 (31)*
Gensini score 2823 3228 5434*
Data are presented as means SD, number of patients (%). MDCT, 64-multi
detector computed tomography; PFV, pericardial fat volume; PFVi, indexed
pericardial fat volume.
* p<0.05 compared to the low-tertile group.
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Study sample characteristics
Table 1 lists the clinical characteristics of the study population
by tertiles of PFVi.Most patientsweremen (77%), and themean age
of all patients was 68  10 years. BMI and waist circumference were
signiﬁcantly larger and hypertension was more common in the high-
tertile group than in the low-tertile group (p < 0.05). HDL-cholesterol
was lower in the high-tertile group than in the low-tertile group
(p < 0.05), and the prevalence of MetS was 41%. Fig. 1 shows a
representative case of a patient with MetS with a large amount of
pericardial fat.
Overall, the mean PFVi was 102  35 (range 35–210) cm3/m2.
Three-vessel diseasewasmore frequent in the high-tertile group than
in the other groups (p < 0.05) (Table 2). GS was signiﬁcantly different
between the high-tertile group and the low-tertile group (p < 0.05),
indicating a stepwise decrease in GS from high-tertile to mid-tertile
and to low-tertile.
Correlations between PFVi, BMI, and the Gensini score
PFVi correlated positively with BMI (r = 0.376, p = 0.0001;
Fig. 2A). GS had a signiﬁcant positive correlation with PFVi
(r = 0.514, p < 0.0001; Fig. 2B). However, no signiﬁcant association
was found between GS and BMI or waist circumference.
Factors associated with the Gensini score
Multiple risk factors have been associated with the severity of
CAD, including age, HDL-cholesterol, and PFVi. The results of
univariate and multivariate linear regression analyses examining
the association between GS and these risk factors are shown in
Table 3. On univariate linear regression analysis, multiple risk
factors, including age, HDL-cholesterol and PFVi, were signiﬁcantly
related to GS (r = 0.248, r = 0.329, and r = 0.514, respectively,
p < 0.05). Multiple regression analysis was performed to identify
the independent risk factors associated with the GS. HDL-
cholesterol (B = 0.587; 95% CI: 1.049 to 0.126, p = 0.013),
and PFVi (B = 0.423; 95% CI: 0.235–0.611, p < 0.001) were the
strongest independent variables related to the Gensini score.
Discussion
Major ﬁndings
The present study demonstrated the relationship between
coronary stenosis and PFVi as measured by MDCT. The major[(Fig._2)TD$FIG]r = 0.376
y = 0.033x + 21.16
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Fig. 2. Regression plots showing the correlations between indexed pericardial fat volume values (PFVi) and (A) body mass index (BMI), (B) the Gensini score. PFVi had a
signiﬁcant positive correlation with BMI (r = 0.376, p = 0.0001), Gensini score (r = 0.514, p < 0.0001).
Table 3
Correlations between the Gensini score and cardiovascular risk factors.
Univariate linear regression
r p
Age, years 0.248 0.014
Sex, male 0.003 0.980
Body mass index 0.135 0.186
Waist circumferences 0.198 0.070
Hypertension 0.191 0.060
LDL-cholesterol 0.122 0.237
HDL-cholesterol 0.329 0.001
Triglyceride 0.015 0.885
Fasting plasma glucose 0.095 0.342
Hemoglobin A1c 0.093 0.381
Metabolic syndrome 0.181 0.079
Active smoking 0.068 0.520
PFVi 0.514 <0.001
Mutivariate linear regression (r=0.554, p<0.001)
B (95% CI) b p
HDL-cholesterol 0.587 (1.049 to 0.126) 0.26 0.013
PFVi 0.423 (0.235–0.611) 0.46 <0.001
LDL, low-density lipoprotein; HDL, high-density lipoprotein; PFVi, indexed
pericardial fat volume; CI, conﬁdence interval.
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previous observations [4,6], it was demonstrated that accumula-
tion of PFVi was related to increased severity of CAD in patients
with preserved ejection fraction. Second, PFVi was positively
correlated with BMI and was increased in CAD subjects. Third, it
was found that the coronary severity score may not be correlated
with BMI and waist circumference. This result may be affected by
the fact that the number of obese patients was small, and the
degree of obesity of most patients in this study was not severe.
Finally, high PFVi was the independent predictor of the severity of
coronary disease, but markers of visceral adiposity (BMI and waist
circumference) were not. Of interest, PFVi remained a signiﬁcant
predictor, suggesting that PFVi is not purely a reﬂection of VAT in
the predisposition to atherosclerosis. The present study is the ﬁrst
to ﬁnd that accumulation of PFVi was related to increased severity
of signiﬁcant atherosclerotic disease in symptomatic CAD subjects.
Role of pericardial fat in the pathophysiology
Pericardial adipose tissue is recognized as ectopic fat depot in
close proximity to the myocardium and coronary arteries, and it is
suspected to be implicated in the pathogenesis of coronary
atherosclerosis. It has been hypothesized that, unlike large fat
deposits, such as visceral abdominal fat, which primarily act
systemically, pericardial fat probably acts locally through
mechano-structural or paracrine mechanisms. Several studies
have reported the potential role of epicardial fat in the
pathophysiology of coronary atherogenesis [1,2,7], and hypotheti-
cal mechanisms of epicardial fat in coronary atherogenesis have
been proposed [12], such as an endocrine effect through adventitial
vasa vasorum. Just like coronary arteries, coronary veins are also
surrounded by pericardial fat. Therefore, pericardial fat surround-
ing the thin-walled coronary veins may exert greater systemic
effects by diffusion of its small, metabolically activemolecules into
the circulation. There may also be a direct paracrine effect.
Adipokines can diffuse in the interstitial ﬂuid across the vascular
wall and stimulate atherogenesis. Pericardial fat is a metabolically
active fat depot that is in anatomic proximity to the myocardium,
sharing the same microcirculation, and may have important
paracrine effects.
In addition, Konishi et al. [7] have shown that pericardial fat had
signiﬁcantly more leukocyte common antigen-positive cells inCAD autopsy cases. Hirata et al. [1] reported that coronary
atherosclerosis is associated with macrophage polarization in
epicardial adipose tissue. Although the exact pathophysiologic
mechanism has not been characterized, it has been hypothesized
that pericardial fat releases pro-atherogenic inﬂammatory cyto-
kines in close proximity to the coronary arteries [3]. Hirata et al. [2]
suggested that chronic inﬂammation in epicardial fat may
inﬂuence the pathogenesis of coronary atherosclerosis by inﬂam-
matory cell inﬁltration in patients with CAD. Recent reports by
other investigators have suggested that epicardial fat may act as a
paracrine organ that affects the coronary arteries by promoting
chronic inﬂammation [13] and endothelial dysfunction.
Atherosclerotic plaque formation involves a cascade of events,
initiated by endothelial dysfunction, followed by inﬂammatory cell
inﬁltration into the intima, transcytosis of cholesterol-rich
lipoproteins, oxidative modiﬁcation, foam cell formation, and
smooth muscle cell proliferation.
Pericardial fat as a predictor of CAD
Previous studies have demonstrated that pericardial fat could
mediate the development of CAD. It has been found that pericardial
fat could contribute to coronary atherosclerosis, myocardial
ischemia [14], coronary plaque characteristics [12], and future
cardiovascular events [15]. In the present study, PFVi was related
to the presence, extension, and stenosis severity of coronary
plaque. These ﬁndings are in good agreement with a recent report
by Mahabadi et al. [16], who found that epicardial fat is associated
with coronary events in the general population independent of
cardiovascular risk factors.
Furthermore, the PFVi was comparable among patients with
stenotic and non-stenotic plaques, suggesting that the accumula-
tion of pericardial fat is associated with early stages of coronary
atherogenesis. Pericardial adipose tissue plays a crucial role in the
development of CAD and atherosclerosis, beyond systemic obesity.
In this study, PFVi was found to be independently associated with
CAD severity, even though it is a small amount of body fat. These
ﬁndings suggest that pericardial fat is more highly associated with
the early development of CAD than simple anthropometric
measures of abdominal obesity.
Hence, PFVi measurement may provide novel, additional risk
stratiﬁcation for patients suspected of having CAD, as well as
visceral adipose tissue [17]. Together, these results suggest that an
increased PFVi may serve as a marker for severe atherosclerosis
and might also be a risk factor for signiﬁcant CAD in the general
population. Furthermore, PFVi assessment could contribute to the
prevention and management of CAD in patients with preserved
ejection fraction. The present ﬁnding that the association of PFVi
with coronary atherosclerosis was not completely explained by
standard risk factors is consistent with the evidence suggesting
that the link between PFVi and obesity-related complications may
involve novel biological pathways.
Study limitations
The present study has several limitations. First, we did not have
data on visceral fat measurements, which could have inﬂuenced
the incident CAD [17]. Instead, we used BMI and waist circumfer-
ence as surrogatemarkers of visceral adiposity, and the inclusion of
these markers in the multivariate model did not attenuate the
association of PFVi with the severity of CAD.
Second, data were obtained in routine medical care. Therefore,
we could not measure serum or tissue inﬂammatory cytokines and
adipokines, both of which can lead to accelerated atherosclerosis
or plaque vulnerability. However, our main aim was to investigate
the relationship between the PFVi and the severity of CAD.
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self-referred patients may have harbored an inherent bias. Finally,
no follow-up data were available. Indeed, whether PFVi quantity
may have a prognostic value needs to be evaluated in prospective
follow-up studies.
Conclusions
This study demonstrated a signiﬁcant association between the
severity of CAD and PFVi, but not with waist circumference or BMI.
Importantly, PFVi with preserved ejection fraction might be more
highly associated with the progression of IHD. Therefore, PFVi
measurementmaybeviewedasanindicatorofglobalatherogenicrisk.
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